diazoxide has been researched along with Beckwith-Wiedemann Syndrome in 5 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
Beckwith-Wiedemann Syndrome: A syndrome of multiple defects characterized primarily by umbilical hernia (HERNIA, UMBILICAL); MACROGLOSSIA; and GIGANTISM; and secondarily by visceromegaly; HYPOGLYCEMIA; and ear abnormalities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diazoxide, a drug used to treat hyperinsulinemic hypoglycemia (HH), is associated with pulmonary hypertension (PH), as reported by the US Food and Drug Administration." | 7.96 | Pulmonary Hypertension Following Increased Dosing of Diazoxide in an Infant. ( Hasegawa, S; Kimura, S; Ohnishi, Y; Okada, S; Suzuki, Y; Yasudo, H, 2020) |
| "Diazoxide, a drug used to treat hyperinsulinemic hypoglycemia (HH), is associated with pulmonary hypertension (PH), as reported by the US Food and Drug Administration." | 3.96 | Pulmonary Hypertension Following Increased Dosing of Diazoxide in an Infant. ( Hasegawa, S; Kimura, S; Ohnishi, Y; Okada, S; Suzuki, Y; Yasudo, H, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shah, N | 1 |
| Khadilkar, A | 1 |
| Khadilkar, V | 1 |
| Lad, S | 1 |
| Ohnishi, Y | 1 |
| Okada, S | 1 |
| Yasudo, H | 1 |
| Kimura, S | 1 |
| Suzuki, Y | 1 |
| Hasegawa, S | 1 |
| Lord, K | 1 |
| De León, DD | 1 |
| Soltész, G | 1 |
| Aynsley-Green, A | 1 |
| Santucci, S | 1 |
| Tosi, M | 1 |
| Marazzini, P | 1 |
| Barp, S | 1 |
| Bertoletti, A | 1 |
2 reviews available for diazoxide and Beckwith-Wiedemann Syndrome
| Article | Year |
|---|---|
Hyperinsulinism in the Neonate.
Topics: Abnormalities, Multiple; Antihypertensive Agents; Beckwith-Wiedemann Syndrome; Congenital Hyperinsul | 2018 |
Hyperinsulinism in infancy and childhood.
Topics: Beckwith-Wiedemann Syndrome; Blood Glucose; Child, Preschool; Diazoxide; Erythroblastosis, Fetal; Fe | 1984 |
3 other studies available for diazoxide and Beckwith-Wiedemann Syndrome
| Article | Year |
|---|---|
Rare association of Beckwith-Wiedemann syndrome with Hirschsprung's disease in an infant with hypoglycemia.
Topics: Beckwith-Wiedemann Syndrome; Combined Modality Therapy; Diazoxide; Female; Hirschsprung Disease; Hum | 2020 |
Pulmonary Hypertension Following Increased Dosing of Diazoxide in an Infant.
Topics: Atrial Natriuretic Factor; Beckwith-Wiedemann Syndrome; Cardiac Catheterization; Congenital Hyperins | 2020 |
[Long-term diazoxide therapy of the Beckwith-Wiedemann syndrome with persistent hypoglycemia].
Topics: Beckwith-Wiedemann Syndrome; Diazoxide; Humans; Hyperinsulinism; Hypoglycemia; Infant | 1982 |